Jocelyn A Allyn, FNPC | |
1023 Medical Center Pkwy, Suite 310, Selma, AL 36701-6780 | |
(334) 418-6656 | |
(334) 418-6657 |
Full Name | Jocelyn A Allyn |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 21 Years |
Location | 1023 Medical Center Pkwy, Selma, Alabama |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1629110895 | NPI | - | NPPES |
186350 | Other | MO | MO BLUE SHIELD |
428402101 | Medicaid | MO | |
82738 | Other | AR | ARK BLUE SHIELD |
157481758 | Medicaid | AR |
Facility Name | Location | Facility Type |
---|---|---|
Vaughan Regional Medical Center Parkway Campus | Selma, AL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Vaughan Physician Practices, Llc | 8123126851 | 11 |
News Archive
Babies with the rare, deadly genetic disorder Sandhoff disease begin to miss developmental milestones just months after birth. Lacking muscle tone, they never learn to sit up, develop heads too large to lift and eventually suffer uncontrollable seizures. There is no cure.
The University of Sydney's Driver Rehabilitation Clinic is seeking participants for the trial of a new specialised driver training program that aims to assist young people with Asperger Syndrome (AS) to learn to drive safely.
Reuters reports that HMO stocks are slipping lower today, in the aftermath of the Congressional Budget Office's analysis of the Senate Finance Committee health care reform bill.
Sanofi-aventis announced today that the investigational once-daily oral drug teriflunomide significantly reduced annualized relapse rate (ARR) at 2 years versus placebo in patients with relapsing multiple sclerosis (RMS), thus achieving the primary endpoint in the TEMSO phase III trial.
› Verified 7 days ago
Entity Name | Vaughan Physician Practices, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467599621 PECOS PAC ID: 8123126851 Enrollment ID: O20070604000705 |
News Archive
Babies with the rare, deadly genetic disorder Sandhoff disease begin to miss developmental milestones just months after birth. Lacking muscle tone, they never learn to sit up, develop heads too large to lift and eventually suffer uncontrollable seizures. There is no cure.
The University of Sydney's Driver Rehabilitation Clinic is seeking participants for the trial of a new specialised driver training program that aims to assist young people with Asperger Syndrome (AS) to learn to drive safely.
Reuters reports that HMO stocks are slipping lower today, in the aftermath of the Congressional Budget Office's analysis of the Senate Finance Committee health care reform bill.
Sanofi-aventis announced today that the investigational once-daily oral drug teriflunomide significantly reduced annualized relapse rate (ARR) at 2 years versus placebo in patients with relapsing multiple sclerosis (RMS), thus achieving the primary endpoint in the TEMSO phase III trial.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Jocelyn A Allyn, FNPC Po Box 1206, Selma, AL 36702-1206 Ph: () - | Jocelyn A Allyn, FNPC 1023 Medical Center Pkwy, Suite 310, Selma, AL 36701-6780 Ph: (334) 418-6656 |
News Archive
Babies with the rare, deadly genetic disorder Sandhoff disease begin to miss developmental milestones just months after birth. Lacking muscle tone, they never learn to sit up, develop heads too large to lift and eventually suffer uncontrollable seizures. There is no cure.
The University of Sydney's Driver Rehabilitation Clinic is seeking participants for the trial of a new specialised driver training program that aims to assist young people with Asperger Syndrome (AS) to learn to drive safely.
Reuters reports that HMO stocks are slipping lower today, in the aftermath of the Congressional Budget Office's analysis of the Senate Finance Committee health care reform bill.
Sanofi-aventis announced today that the investigational once-daily oral drug teriflunomide significantly reduced annualized relapse rate (ARR) at 2 years versus placebo in patients with relapsing multiple sclerosis (RMS), thus achieving the primary endpoint in the TEMSO phase III trial.
› Verified 7 days ago
Jewels M Knight, FNP-C, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1475 Al Highway 14 E, Selma, AL 36703 Phone: 334-526-3240 Fax: 334-526-3241 | |
Kelly Butler, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1475 Al Highway 14 E, Selma, AL 36703 Phone: 334-526-3240 | |
Tacarla Shantese Pearson, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1023 Medical Center Pkwy Ste 200, Selma, AL 36701 Phone: 334-875-4184 | |
Terry Dunson, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1015 Medical Center Pkwy, Selma, AL 36701 Phone: 334-418-6646 Fax: 334-418-6647 | |
Tamarah Mason, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 203 Vaughan Memorial Dr, Selma, AL 36701 Phone: 334-375-8007 Fax: 334-526-1849 | |
Mrs. Monica Boswell Moore, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1015 Medical Center Parkway, Selma, AL 36701 Phone: 334-418-4150 Fax: 334-418-3592 | |
Geraldine Davis Turner, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4258 Us Highway 80 W, Selma, AL 36701 Phone: 334-874-8800 |